Preliminary evidence suggests that children with higher baseline ferritin or zinc levels may respond better to stimulant treatment,² ⁰,²¹ highlighting the importance of nutritional optimisation during pharmacotherapy.²²
The Emerging Role of Vitamin D and Inflammation
Vitamin D deficiency is consistently overrepresented in ADHD cohorts ²³,² ⁴. Beyond its immunomodulatory role, vitamin D interacts with dopaminergic neurons through regulation of tyrosine hydroxylase expression ² ⁵. Low vitamin D levels have been linked with elevated proinflammatory cytokines ² ⁶,² ⁷, potentially exacerbating neuroinflammation— a proposed contributor to ADHD pathophysiology ² ⁸.
Psychostimulant-related microbiota shifts that reduce SCFA production could indirectly amplify inflammation and compromise vitamin D metabolism via hepatic pathways.² ⁹, ³¹ Addressing vitamin D insufficiency— through safe sunlight exposure, diet, and monitored supplementation— may therefore support bone and immune health as well as mood, cognition, and attention regulation.³²
Gut Microbiota, Metabolomics, and Future Directions
Advances in metabolomic profiling are beginning to clarify how medications and microbiota interact to influence nutrient handling. Tang et al. demonstrated that modulation of gut microbiota in ADHD animal models normalised peripheral metabolite profiles and improved behavioural outcomes.³³ Additional metabolomic studies support the role of microbiota-derived metabolites in influencing nutrient absorption, neurotransmitter synthesis, and inflammatory pathways relevant to ADHD.³ ⁴,³ ⁵
Similarly, studies investigating combined methylphenidate and French maritime pine bark extract interventions suggest that antioxidant and prebiotic effects may stabilise microbial composition and improve behavioural outcomes.³ ⁶- ³ ⁸
Clinical Implications
Baseline nutritional assessment: Evaluate ferritin, zinc, magnesium, and vitamin D before commencing stimulant therapy.
Growth and appetite monitoring: Track height, weight, BMI, and appetite regularly.
Dietary support: Encourage nutrientdense meals and align medication timing with main meals.
Microbiota consideration: Address dysbiosis through diet and probiotics when indicated.
Individualised supplementation: Prescribe nutrients only where deficiencies are confirmed.
Holistic care: Integrate sleep, exercise, and stress regulation to support neurochemical balance.
Research Gaps
Significant gaps persist. Large-scale longitudinal studies are required to clarify causality between medication use and nutritional changes. Mechanistic links between psychostimulant-induced microbiota shifts and micronutrient absorption remain speculative. Adult ADHD cohorts remain underrepresented, and few interventional trials test whether correcting deficiencies enhances treatment response.
Conclusion
Current evidence indicates that ADHD medications do not directly deplete nutrients but, through appetite suppression, microbiome alterations, and inflammatory influences, can create conditions conducive to deficiency. Integrative management— grounded in nutritional assessment, microbiome awareness, and personalised supplementation— offers a more complete therapeutic model, utlising nutritionists and naturopaths as part of a holistic support team.
Understanding ADHD through a nutritional-neurobiological lens reframes medication not as an isolated intervention but as part of a broader metabolic ecosystem. As research deepens into gut – brain interactions and nutrient – neurotransmitter dynamics, future paradigms may move toward truly multidisciplinary care— where stimulants, nutrients, and lifestyle interventions work synergistically to optimise brain function and wellbeing.
REFERENCES
1. Skalny AV, Skalnaya MG, Grabeklis AR, et al. Serum zinc, copper, and magnesium levels in children and adolescents with attention deficit hyperactivity disorder( ADHD). Nutrients. 2020; 12( 7): 198.
2. Cortese S, Azoulay R, Castellanos FX, et al. Brain imaging of attention-deficit / hyperactivity disorder: a systematic review. J Atten Disord. 2012; 16( 8): 279 – 288.
3. Wang Y, Huang L, Zhang L, et al. Vitamin D deficiency and risk of attention deficit hyperactivity disorder: a meta-analysis. PLoS One. 2017; 12( 2): e0172682.
4. Arnold LE, DiSilvestro RA. Zinc in attentiondeficit / hyperactivity disorder. Nutr Rev. 2018; 76( 6): 471 – 490.
5. Boonchooduang N, Louthrenoo O, Chattipakorn N, et al. Impact of psychostimulants on gut microbiota and short-chain fatty acids in children with ADHD. Sci Rep. 2025; 15:4452.
6. Stiernborg M, Westrin Å, Holmer RH, et al. Gut microbiota composition in medicated and unmedicated children with attentiondeficit / hyperactivity disorder. Brain Behav Immun. 2023; 115:134 – 145.
7. Morrison DJ, Preston T. Formation of shortchain fatty acids by the gut microbiota and their impact on human metabolism. J Nutr. 2016; 146( 1): 1 – 9.
8. Sukmajaya AC, Wibowo A, Prabowo A, et al. Gut microbiota and attention-deficit / hyperactivity disorder: a systematic review. Ann Gen Psychiatry. 2021; 20:22.
9. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. World Psychiatry. 2015; 14( 3): 372 – 381.
10. Faraone SV, Biederman J. Neurobiology of attention-deficit / hyperactivity disorder. Neurosci Biobehav Rev. 2016; 87:255 – 270.
200 | vol31 | no4 | AJNM